arginine and Cancer of Cervix

arginine has been researched along with Cancer of Cervix in 55 studies

Research

Studies (55)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (9.09)	18.7374
1990's	17 (30.91)	18.2507
2000's	20 (36.36)	29.6817
2010's	9 (16.36)	24.3611
2020's	4 (7.27)	2.80

Authors

Authors	Studies
Chang, X; Dong, Z; Hou, Y; Wang, Y; Xie, L	1
Hagihara, T; Hishinuma, E; Kinoshita, K; Koshiba, S; Li, B; Matsukawa, N; Motoike, IN; Saigusa, D; Shigeta, S; Shimada, M; Tokunaga, H; Yaegashi, N	1
Dong, L; Hong, W; Huang, H; Pang, Z; Ren, Y; Wang, H; Wu, H; Yang, X; Zhang, J; Zhao, Z	1
Chen, G; Ding, W; Li, K; Ma, D; Nansubuga, F; Wei, J; Weng, D; Wu, P; Yang, J; Yu, R	1
Li, Q; Liang, N; Sun, S; Yan, C; Yan, P	1
Huang, L; Sun, H; Wang, F; Wu, Q; Yang, E; Zhang, G; Zhang, Z	1
Dem, A; Diop, G; Diop, PA; Faye, O; Guèye, PM; Mbaye, PM; Ndiaye, R	1
Baena, A; Bedoya, AM; Borrero, M; Córdoba, CM; Herrero, R; Pareja, R; Patterson, JR; Rojas, F; Sanchez, GI; Tate, DJ; Zea, AH	1
Cao, XL; Gao, JX; Li, LF; Liu, N; Liu, SS; Sun, L; Xia, WY; Xiu, P; Zhao, SH	1
Jiang, JF; Li, HA; Li, XM; Pan, XL; Wang, XL; Yan, LH; Yang, AQ; Zhang, B; Zheng, LL; Zheng, XZ; Zhou, QY	1
Jiang, P; Li, W; Liu, J; Tang, J; Zeng, X	1
Li, SW; Li, Y; Liu, F; Tan, SQ; Wang, Y	1
Chen, F; Di, J; Li, H; Li, L; Liu, J; Pei, D; Tian, H; Zhang, B; Zheng, J	1
Batra, S; Bhambani, S; Bharadwaj, M; Hussain, S; Salhan, S; Singhal, P; Thakur, N	1
Contractor, R; Dedhia, P; Dinshaw, K; Khan, Z; Saranath, D; Sharma, B; Shrivastava, S; Tandle, AT	1
Gallegos-Arreola, MP; Montoya-Fuentes, H; Morán-Moguel, MC; Sánchez-Corona, J; Suárez-Rincón, AE	1
Herman, B; Jayaprakash, PG; Pillai, MR; Pollock, BH; Sreevidya, S	1
Qie, M; Wu, J; Zhang, Y	1
Das, BC; Gopalkrishna, V; Hedau, S; Husain, SA; Jain, N; Katiyar, S; Murthy, NS; Thelma, BK	1
Brenna, SM; Martinez, EZ; Pereira, JS; Silva, ID; Syrjänen, KJ; Zeferino, LC	1
Misra, C; Mitra, S; Panda, CK; Roychoudhury, S; Singh, RK	1
Bhattacharya, P; Sengupta, S	1
Coutlée, F; Duarte-Franco, E; Forest, P; Franco, EL; Ghosh, A; Koushik, A; Matlashewski, G; Voyer, H	1
Govan, VA; Hoffman, M; Loubser, S; Saleh, D; Williamson, AL	1
Arai, H; Izumi, S; Kurihara, S; Nozawa, S; Ohta, H	1
Herzog, RE	2
Fuchs, D; Hausen, A; Mayer, B; Reibnegger, G; Wachter, H; Weiss, G; Werner, ER; Werner-Felmayer, G	1
Blencowe, BJ; Issner, R; Nickerson, JA; Penman, S; Sharp, PA	1
Hittelman, WN; Hong, WK; Lee, JJ; Lotan, R; Mitchell, MF; Nishioka, K; Tortolero-Luna, G; Wharton, JT	1
zur Hausen, H	1
Banks, L; Breuer, J; Gardiol, D; Harwood, C; Kalita, A; Leigh, IM; Mantovani, F; Matlashewski, G; Storey, A; Thomas, M	1
Al-Jehani, RM; Harwood, CA; Jacobs, IJ; Rosenthal, AN; Ryan, A; Storey, A	1
Campbell, I; Gornall, R; Lanham, S; Watt, P	1
Buys, CH; Hayes, VM; Hofstra, RM; Hollema, H; van der Zee, AG	1
Børresen-Dale, AL; Helland, A; Johnsen, H; Langerød, A; Olsen, AO; Skovlund, E	1
Barnes, W; Bratti, MC; Brinton, LA; Carrington, M; Fraumeni, JF; Greenberg, M; Herrera, JE; Herrero, R; Hildesheim, A; Martin, M; McGowan, L; Mortel, R; Schiffman, M; Schwartz, P; Scott, DR	1
Bertorelle, R; Chieco-Bianchi, L; Del Mistro, A	1
Chang, JG; Chen, SJ; Tsai, CH; Wang, NM; Yeh, KT	1
Giannoudis, A; Graham, DA; Herrington, CS; Southern, SA	1
Liu, SS; Liu, VW; Ngan, HY	1
Mikysková, I; Saláková, M; Tachezy, R; Van Ranst, M	1
Carter, JJ; Daling, JR; Galloway, DA; Madeleine, MM; McDougall, JK; McKnight, B; Schwartz, SM; Shera, K; Wipf, GC	1
Baek, WK; Cha, SD; Cho, CH; Cho, JW; Lee, TS; Shin, DH; Suh, MH; Suh, SI	1
Baber, GB; Boyd, JC; Malcolm, EK; Stoler, MH	1
Carnevali, L; Migliora, P; Ranzani, GN; Rondo Spaudo, M; Tenti, P; Vesentini, N; Zappatore, R	1
Kim, IK; Kim, JW; Kim, KS; Lee, CG; Lee, JM; Min, HK; Namkoong, SE; Park, YG; Sohn, YW	1
Agorastos, T; Bontis, JN; Constantinidis, TC; Kotsis, A; Lambropoulos, AF	1
Dudley, R; Franco, EL; Kaiano, J; Labrecque, S; Makni, H; Matlashewski, G; Storey, A; Villa, LL	1
Lanning, P; Moodley, J; Naiker, S; Pegoraro, R; Rom, L	1
Andersson, S; Delius, H; Edler, L; Klimek, F; Marongiu, A; Tommasino, M; Voglino, G; Wilander, E; Zehbe, I	1
Bundy, BN; Given, FT; Muss, HB; Stehman, FB	1
Bertelsen, K; Cold, S; Panduro, J; Pfeiffer, P; Rose, C; Sandberg, E	1
Coffman, FD; Godwin, A; Green, LM; Ware, CF	1
Bundy, BN; Muss, HB; Yazigi, R; Yordan, E	1

Reviews

1 review(s) available for arginine and Cancer of Cervix

Article	Year
X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis. PloS one, 2012, Volume: 7, Issue:9 Topics: Arginine; Asian People; DNA Damage; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Glutamine; Humans; Odds Ratio; Polymorphism, Genetic; Risk; Risk Factors; Tryptophan; Uterine Cervical Neoplasms; X-ray Repair Cross Complementing Protein 1	2012

Article

Year

X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.

PloS one, 2012, Volume: 7, Issue:9

Topics: Arginine; Asian People; DNA Damage; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Glutamine; Humans; Odds Ratio; Polymorphism, Genetic; Risk; Risk Factors; Tryptophan; Uterine Cervical Neoplasms; X-ray Repair Cross Complementing Protein 1

2012

Trials

2 trial(s) available for arginine and Cancer of Cervix

Article	Year
Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery. Medicine, 2020, Jun-19, Volume: 99, Issue:25 Topics: Anticoagulants; Arginine; Endometrial Neoplasms; Female; Gynecologic Surgical Procedures; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms; Pipecolic Acids; Postoperative Complications; Risk Factors; Sulfonamides; Uterine Cervical Neoplasms; Venous Thrombosis	2020
Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:2 Topics: Administration, Oral; Adult; Antineoplastic Agents; Arginine; Biogenic Polyamines; Dose-Response Relationship, Drug; Drug Administration Schedule; Eflornithine; Enzyme Inhibitors; Female; Humans; Ornithine; Ornithine Decarboxylase; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	1998

Article

Year

Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery.

Medicine, 2020, Jun-19, Volume: 99, Issue:25

Topics: Anticoagulants; Arginine; Endometrial Neoplasms; Female; Gynecologic Surgical Procedures; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms; Pipecolic Acids; Postoperative Complications; Risk Factors; Sulfonamides; Uterine Cervical Neoplasms; Venous Thrombosis

2020

Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:2

Topics: Administration, Oral; Adult; Antineoplastic Agents; Arginine; Biogenic Polyamines; Dose-Response Relationship, Drug; Drug Administration Schedule; Eflornithine; Enzyme Inhibitors; Female; Humans; Ornithine; Ornithine Decarboxylase; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

1998

Other Studies

52 other study(ies) available for arginine and Cancer of Cervix

Article	Year
Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma. Bioengineered, 2022, Volume: 13, Issue:3 Topics: Arginine; Carcinoma, Squamous Cell; Female; Humans; Prognosis; Protein Serine-Threonine Kinases; Retrospective Studies; RNA, Messenger; Serine; Uterine Cervical Neoplasms	2022
Identification of predictive biomarkers for diagnosis and radiation sensitivity of uterine cervical cancer using wide-targeted metabolomics. The journal of obstetrics and gynaecology research, 2023, Volume: 49, Issue:8 Topics: Arginine; Biomarkers; Female; Humans; Metabolome; Metabolomics; Radiation Tolerance; Uterine Cervical Neoplasms	2023
Discovery of 2,4-diphenyl-substituted thiazole derivatives as PRMT1 inhibitors and investigation of their anti-cervical cancer effects. Bioorganic & medicinal chemistry, 2023, 09-07, Volume: 92 Topics: Arginine; Biphenyl Compounds; Enzyme Inhibitors; Female; HeLa Cells; Humans; Middle Aged; Protein-Arginine N-Methyltransferases; Repressor Proteins; Uterine Cervical Neoplasms	2023
Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel. Carbohydrate polymers, 2019, Jul-15, Volume: 216 Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Arginine; Biotin; Carcinoma; Drug Carriers; Female; Humans; MCF-7 Cells; Mice; Nanoparticles; Paclitaxel; Particle Size; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2019
A recombinant trans-membrane protein hMnSOD-R9 inhibits the proliferation of cervical cancer cells in vitro. Molecular and cellular biochemistry, 2014, Volume: 385, Issue:1-2 Topics: Antioxidants; Apoptosis; Arginine; Blotting, Western; Cell Cycle; Cell Membrane; Cell Proliferation; DNA Damage; Female; Gene Expression Regulation, Neoplastic; Genetic Vectors; HeLa Cells; Humans; Microscopy, Confocal; Polymerase Chain Reaction; Recombinant Fusion Proteins; Superoxide Dismutase; Transduction, Genetic; Uterine Cervical Neoplasms	2014
[Study of codon 72 of p53 gene as a risk-factor in cervical cancer in Senegal]. Bulletin du cancer, 2014, Volume: 101, Issue:9 Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Alleles; Arginine; Case-Control Studies; Codon; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Genetic; Risk Factors; Senegal; Uterine Cervical Neoplasms	2014
Immunosuppression in cervical cancer with special reference to arginase activity. Gynecologic oncology, 2014, Volume: 135, Issue:1 Topics: Adult; Aged; Arginase; Arginine; Carcinoma, Squamous Cell; Female; Humans; Immune Tolerance; Middle Aged; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult	2014
An asymmetrically dimethylarginated nuclear 90 kDa protein (p90aDMA) induced by interleukin (IL)-2, IL-4 or IL-6 in the tumor microenvironment is selectively degraded by autophagy. International journal of oncology, 2016, Volume: 48, Issue:6 Topics: Arginine; Autophagy; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Interleukin-2; Interleukin-4; Interleukin-6; MCF-7 Cells; Molecular Weight; Nuclear Proteins; Protein Processing, Post-Translational; Sirolimus; Tumor Microenvironment; Uterine Cervical Neoplasms	2016
Ethnicity determines association of p53Arg72Pro alleles with cervical cancer in China. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2008, Volume: 17, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Arginine; Base Sequence; Carcinoma; Case-Control Studies; China; Female; Genes, p53; Genetic Linkage; Genetic Predisposition to Disease; Humans; Middle Aged; Molecular Sequence Data; Polymorphism, Single Nucleotide; Proline; Uterine Cervical Neoplasms	2008
Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women. Cancer genetics and cytogenetics, 2010, Volume: 197, Issue:2 Topics: Adult; Arginine; Case-Control Studies; Chi-Square Distribution; China; Codon; Cohort Studies; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Polymorphism, Genetic; Proline; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	2010
Critical role of lysine 123 in the ubiquitin-mediated degradation of MDA-7/IL-24. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2012, Volume: 32, Issue:12 Topics: Apoptosis; Arginine; Caspase 3; Cell Survival; Cysteine Proteinase Inhibitors; Female; HeLa Cells; Humans; Interleukins; Lysine; Mutant Proteins; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; Recombinant Proteins; Signal Transduction; Ubiquitination; Uterine Cervical Neoplasms	2012
Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma. DNA and cell biology, 2013, Volume: 32, Issue:1 Topics: Adult; Aged; Alleles; Arginine; Codon; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Odds Ratio; Papillomavirus Infections; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms; Young Adult	2013
HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecologic oncology, 2002, Volume: 86, Issue:2 Topics: Arginine; Carcinoma, Squamous Cell; Cervix Uteri; Disease Progression; DNA, Viral; Female; Genotype; Humans; India; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Polymorphism, Genetic; Prevalence; Proline; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms; White People	2002
[Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico]. Ginecologia y obstetricia de Mexico, 2002, Volume: 70 Topics: Adult; Arginine; Case-Control Studies; Codon; DNA Mutational Analysis; DNA-Binding Proteins; Exons; Female; Gene Frequency; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; Mexico; Oncogene Proteins, Viral; Papillomaviridae; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Repressor Proteins; Risk Factors; Substrate Specificity; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	2002
Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India. Journal of cancer research and clinical oncology, 2002, Volume: 128, Issue:11 Topics: Arginine; Carcinoma, Squamous Cell; Codon; DNA Primers; DNA, Neoplasm; DNA, Viral; Female; Genes, p53; Genotype; Homozygote; Humans; India; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2002
[Study on the relationship between cervical cancer and p53 codon 72 polymorphism]. Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 2002, Volume: 33, Issue:2 Topics: Alleles; Arginine; Codon; Female; Genes, p53; Genotype; Homozygote; Humans; Polymorphism, Genetic; Proline; Uterine Cervical Neoplasms	2002
Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Molecular and cellular biochemistry, 2003, Volume: 252, Issue:1-2 Topics: Adult; Aged; Arginine; Base Sequence; Case-Control Studies; Codon; DNA Primers; Female; Genes, p53; Humans; India; Middle Aged; Mouth Neoplasms; Papillomaviridae; Polymorphism, Genetic; Proline; Uterine Cervical Neoplasms	2003
Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil. Gynecologic oncology, 2004, Volume: 93, Issue:2 Topics: Arginine; Codon; Disease-Free Survival; Female; Genes, p53; Homozygote; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Polymorphism, Genetic; Uterine Cervical Neoplasms	2004
Association of specific genotype and haplotype of p53 gene with cervical cancer in India. Journal of clinical pathology, 2005, Volume: 58, Issue:1 Topics: Adult; Arginine; Carcinoma, Squamous Cell; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Middle Aged; Neoplasm Staging; Papillomaviridae; Polymorphism, Genetic; Uterine Cervical Neoplasms	2005
Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Gynecologic oncology, 2005, Volume: 99, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Arginine; Cell Cycle Proteins; Codon; Cyclin-Dependent Kinase Inhibitor p21; DNA, Neoplasm; DNA, Viral; Female; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; India; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polymorphism, Restriction Fragment Length; Proline; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	2005
The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer detection and prevention, 2005, Volume: 29, Issue:4 Topics: Adult; Arginine; Canada; Case-Control Studies; Codon; DNA, Neoplasm; Female; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Odds Ratio; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Proline; Risk Factors; Sequence Analysis, DNA; Tumor Suppressor Protein p53; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2005
No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency. International journal of immunogenetics, 2007, Volume: 34, Issue:3 Topics: Arginine; Case-Control Studies; Codon; Female; Gene Frequency; Genes, p53; Genotype; Humans; Papillomavirus Infections; South Africa; Uterine Cervical Neoplasms	2007
Heat-stable alkaline phosphatase in normal uterus and deviation of isozyme profile during uterine carcinogenesis. Progress in clinical and biological research, 1984, Volume: 166 Topics: Alkaline Phosphatase; Arginine; Female; Histocytochemistry; Humans; Isoenzymes; Leucine; Phenylalanine; Uterine Cervical Neoplasms; Uterine Neoplasms; Uterus	1984
Cytophotometric determinations of DNA, histone, arginine, lysine, and their concentrations in eu- and heterochromatin of the cell nucleus of dysplasias, carcinoma in situ, and carcinoma of the human cervix uteri. Archives of gynecology, 1982, Volume: 231, Issue:2 Topics: Arginine; Carcinoma; Carcinoma in Situ; Cell Nucleus; Chromatin; DNA, Neoplasm; Female; Heterochromatin; Histones; Humans; Lysine; Mathematics; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	1982
Ca2+/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. The Biochemical journal, 1993, Jan-15, Volume: 289 ( Pt 2) Topics: Amino Acid Oxidoreductases; Arginine; Calcium; Calmodulin; Cyclic GMP; Female; Humans; Interferon-gamma; Kinetics; Lipopolysaccharides; Nitric Oxide Synthase; omega-N-Methylarginine; Pteridines; Recombinant Proteins; Tumor Cells, Cultured; Uterine Cervical Neoplasms	1993
Association of nuclear matrix antigens with exon-containing splicing complexes. The Journal of cell biology, 1994, Volume: 127, Issue:3 Topics: Amino Acid Sequence; Antibodies, Monoclonal; Antigen-Antibody Complex; Antigens, Nuclear; Arginine; Autoantigens; Blotting, Western; Cell Nucleus; Exons; Female; HeLa Cells; Humans; Microscopy, Immunoelectron; Nuclear Matrix; Nuclear Proteins; Ribonucleoproteins, Small Nuclear; RNA Precursors; RNA Splicing; Serine; Tumor Cells, Cultured; Uterine Cervical Neoplasms	1994
Papillomavirus and p53. Nature, 1998, May-21, Volume: 393, Issue:6682 Topics: Arginine; DNA-Binding Proteins; Female; Humans; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Repressor Proteins; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms	1998
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature, 1998, May-21, Volume: 393, Issue:6682 Topics: Alleles; Arginine; Carcinoma, Squamous Cell; Disease Susceptibility; DNA-Binding Proteins; Female; Gene Deletion; Genotype; Heterozygote; Humans; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Repressor Proteins; Skin Neoplasms; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms	1998
p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Amino Acid Sequence; Arginine; Carcinoma, Squamous Cell; Codon; Disease Susceptibility; Female; Genes, p53; Genotype; Heterozygote; Homozygote; Humans; Polymorphism, Genetic; Proline; Risk Factors; United Kingdom; Uterine Cervical Neoplasms	1998
p53 polymorphism and risk of cervical cancer. Lancet (London, England), 1998, Nov-14, Volume: 352, Issue:9140 Topics: Alleles; Arginine; Case-Control Studies; Female; Genes, p53; Humans; Polymorphism, Genetic; Prevalence; Risk Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	1998
Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet (London, England), 1998, Nov-28, Volume: 352, Issue:9142 Topics: Alleles; Arginine; Cell Transformation, Neoplastic; Female; Genetic Predisposition to Disease; Homozygote; Humans; Neoplasm Staging; Papillomaviridae; Papillomavirus Infections; Proline; Risk Factors; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	1998
p53 polymorphism and risk of cervical cancer. Nature, 1998, Dec-10, Volume: 396, Issue:6711 Topics: Alleles; Arginine; Breast Neoplasms; DNA-Binding Proteins; Female; Gene Frequency; Genes, p53; Genetic Predisposition to Disease; Humans; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Repressor Proteins; Risk Factors; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	1998
p53 polymorphism and risk of cervical cancer. Nature, 1998, Dec-10, Volume: 396, Issue:6711 Topics: Arginine; DNA-Binding Proteins; Female; Genes, p53; Genetic Predisposition to Disease; Humans; Oncogene Proteins, Viral; Papillomaviridae; Polymorphism, Genetic; Repressor Proteins; Risk Factors; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	1998
Papillomavirus and p53 codon 72 polymorphism. International journal of cancer, 1999, Aug-12, Volume: 82, Issue:4 Topics: Arginine; Case-Control Studies; Cell Division; Codon; Female; Genes, p53; Genetic Predisposition to Disease; Humans; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Tumor Virus Infections; Uterine Cervical Neoplasms	1999
P53 codon 72Arg polymorphism is not a risk factor for carcinogenesis in the chinese. International journal of molecular medicine, 1999, Volume: 4, Issue:3 Topics: Arginine; Carcinoma; China; Female; Genotype; Humans; Papillomaviridae; Polymorphism, Genetic; Risk Factors; Sequence Analysis; Taiwan; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	1999
p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix. International journal of cancer, 1999, Sep-24, Volume: 83, Issue:1 Topics: Arginine; Carcinoma, Squamous Cell; Condylomata Acuminata; Female; Genes, p53; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Oncogene Proteins, Viral; Papillomaviridae; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Risk Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	1999
Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. British journal of cancer, 1999, Volume: 80, Issue:11 Topics: Arginine; Asian People; China; Female; Genes, p53; Homozygote; Hong Kong; Humans; Incidence; Papillomaviridae; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	1999
Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism. Human genetics, 1999, Volume: 105, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Blood Donors; Codon; Czech Republic; DNA Mutational Analysis; Female; Genotype; Humans; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms	1999
The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2000, Volume: 9, Issue:2 Topics: Adult; Arginine; Carcinoma, Squamous Cell; Codon; Female; Genes, p53; Humans; Middle Aged; Neoplasm Invasiveness; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Proline; Tumor Virus Infections; Uterine Cervical Neoplasms	2000
p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women. Journal of Korean medical science, 2000, Volume: 15, Issue:1 Topics: Alleles; Arginine; Codon; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; Papillomaviridae; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Risk Factors; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	2000
Polymorphism at codon 72 of p53 is not associated with cervical cancer risk. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2000, Volume: 13, Issue:4 Topics: Adenocarcinoma; Alleles; Arginine; Carcinoma in Situ; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Codon; DNA, Neoplasm; Female; Gene Frequency; Homozygote; Humans; Neoplasm Invasiveness; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	2000
p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2000, Volume: 9, Issue:4 Topics: Adult; Aged; Arginine; Case-Control Studies; Codon; Female; Genes, p53; Genetic Predisposition to Disease; Humans; Italy; Middle Aged; Odds Ratio; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Retrospective Studies; Risk Assessment; Tumor Virus Infections; Uterine Cervical Neoplasms	2000
Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer, 2000, May-01, Volume: 88, Issue:9 Topics: Adult; Arginine; Base Pairing; Carcinoma; Case-Control Studies; Confidence Intervals; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2E1; Exons; Female; Gene Frequency; Genes, p53; Genotype; Glutathione Transferase; Humans; Incidence; Introns; Odds Ratio; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Proline; Risk Factors; Tumor Virus Infections; Uterine Cervical Neoplasms	2000
p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2000, Volume: 9, Issue:2 Topics: Adult; Arginine; Codon; Confidence Intervals; Female; Genes, p53; Genotype; Greece; Humans; Middle Aged; Odds Ratio; Polymorphism, Genetic; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2000
P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. International journal of cancer, 2000, Aug-15, Volume: 87, Issue:4 Topics: Adult; Aged; Arginine; Case-Control Studies; Cocarcinogenesis; Codon; Female; Genes, p53; Genotype; Humans; Middle Aged; Observer Variation; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Reproducibility of Results; Risk Factors; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms	2000
The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer. BJOG : an international journal of obstetrics and gynaecology, 2000, Volume: 107, Issue:9 Topics: Alleles; Arginine; Carcinoma, Squamous Cell; Female; Genes, p53; Humans; Papillomaviridae; Polymorphism, Genetic; Proline; Risk Factors; South Africa; Uterine Cervical Neoplasms	2000
p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer research, 2001, Jan-15, Volume: 61, Issue:2 Topics: Arginine; Codon; Cohort Studies; Cross-Sectional Studies; DNA Mutational Analysis; DNA, Neoplasm; Female; Genotype; Humans; Italy; Neoplasm Invasiveness; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Repressor Proteins; Risk Factors; Sweden; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2001
[Proceedings: Quantitative determination of basic amino acids in the cell nucleus of cervix carcinoma and its early stages]. Archiv fur Gynakologie, 1975, Nov-18, Volume: 219, Issue:1-4 Topics: Amino Acids; Arginine; Female; Histones; Humans; Lysine; Precancerous Conditions; Uterine Cervical Neoplasms	1975
Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group. American journal of clinical oncology, 1990, Volume: 13, Issue:2 Topics: Adult; Aged; Carcinoma; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Podophyllotoxin; Prognosis; Teniposide; Uterine Cervical Neoplasms	1990
Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy. Gynecologic oncology, 1990, Volume: 37, Issue:2 Topics: Adult; Aged; Carcinoma; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Survival; Teniposide; Uterine Cervical Neoplasms	1990
Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II. Journal of cellular biochemistry, 1989, Volume: 39, Issue:2 Topics: Cell Communication; Cell Survival; DNA Topoisomerases, Type II; Drug Synergism; Etoposide; Female; Kinetics; Lymphotoxin-alpha; Mitomycin; Mitomycins; Teniposide; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms	1989
Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group. Cancer treatment reports, 1987, Volume: 71, Issue:9 Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Middle Aged; Podophyllotoxin; Teniposide; Uterine Cervical Neoplasms	1987